吉林敖東(000623.SZ):逐步發展成為以醫藥產業為基礎,形成“醫藥+金融+大健康”多輪驅動快速發展模式
格隆匯7月20日丨有投資者向吉林敖東(000623.SZ)提問:公司堅持“醫藥+金融+大健康”多輪驅動的優勢是什麼?
吉林敖東回覆:公司的前身是1957年成立的國營延邊敦化鹿場,於1981年建立敖東製藥廠,1993年經吉林省經濟體制改革委員會批准,成立延邊敖東藥業(集團)股份有限公司,1998年更名為吉林敖東藥業集團股份有限公司,1996年10月28日在深交所掛牌上市。公司始終立足於醫藥產業謀求高質量發展,製藥40多年來,基礎夯實,形成了三大優勢,一是傳承中藥文化,弘揚國藥精髓的敖東品牌優勢;二是每一種藥、每一粒藥都安全、放心、可靠的質量優勢;三是以持有廣發證券為核心優質金融資產的產融結合資本優勢。在公司治理、信息披露、合規運作、投資者權益保護等方面持續努力,公司連續8年深交所信息披露考核結果為A級。2001年,吉林敖東建立母子公司體制,逐步發展成為以醫藥產業為基礎,形成“醫藥+金融+大健康”多輪驅動快速發展模式。
公司業務板塊主要包括醫藥、金融、大健康。醫藥板塊分為中藥、化藥、連鎖藥店的批發和零售三大業務。公司通過投資廣發證券股權並適時進行市值管理,成為廣發證券的第一大股東,廣發證券是公司的核心優質資產,構築成公司資本優勢核心地位。通過股權投資成為第一醫藥第二股東、南京醫藥第四股東、遼寧成大第四股東及投資部分醫藥行業上市公司,同時和廣發信德合作成立基金優選醫藥企業進行投資,以股權投資為紐帶開拓業務合作機會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.